Dow Inc. Stock Rises Monday, Still Underperforms Market

Spectrum Pharmaceuticals Inc

Change company Symbol lookup

Select an option...

SPPI Spectrum Pharmaceuticals Inc

FDBC Fidelity D&D Bancorp Inc

$BUKCHET Bloomberg Coffee Subindex Euro

BMY Bristol-Myers Squibb Co

MLGO MicroAlgo Inc

FRST Primis Financial Corp

VII 7GC & Holdings Co Inc

PEBO Peoples Bancorp Inc

BIOAF Bioasis Technologies Inc

NRGOF Newrange Gold Corp

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value

Company profile

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing targeted oncology therapies. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. The Company's pipeline products include Eflapegrastim and Poziotinib. The Eflapegrastim is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib is a, pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. The Eflapegrastim employs a LAPSCOVERY technology to enhance the duration of therapeutic effects and reduce the frequency of administration.

Dow Inc. Stock Rises Monday, Still Underperforms Market

4:49 pm ET November 7, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Dow Inc. (DOW) inched 0.96% higher to $49.50 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.96% to 3,806.80 and the Dow Jones Industrial Average rising 1.31% to 32,827.00. This was the stock's second consecutive day of gains. Dow Inc. closed $22.36 short of its 52-week high ($71.86), which the company achieved on April 21st.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Linde PLC (LIN) rose 1.48% to $313.49, Air Products & Chemicals Inc. (APD) rose 0.57% to $277.63, and DuPont de Nemours Inc. (DD) fell 0.31% to $61.74. Trading volume (5.8 M) remained 701,800 below its 50-day average volume of 6.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 7, 2022.

(END) Dow Jones Newswires

November 07, 2022 16:49 ET (21:49 GMT)